Oxford awarded more than $3M for cancer imaging

TriMed Staff | | Health Imaging | Diagnostic Imaging
Cancer Research UK, the Engineering and Physical Sciences Research Council (EPSRC) and the Medical Research Council (MRC), has awarded the University of Oxford £2 million ($3.49 million U.S.), as part of a nationwide, five-year investment in cancer imaging.

The university said that the money will be used to develop cancer imaging technologies, such as MRI and PET, as well as equipment to allow scientists to watch cells in action by tracing radioactive biomarkers injected into patients, the BBC reported.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.